Restoration of the Inner Blood–Retinal Barrier in Diabetic Retinopathy Through Norrin-FZD4 Signaling
International Journal of Molecular Sciences · 03.11.2026 · 27 (21) · 9849
DOI: 10.3390/ijms27219849 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2026. Verfasst von Laura González-González und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan Ann Arbor, MI 48105, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Blood-Retinal Barrier, Signal Transduction, Eye Proteins. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a leading cause of irreversible vision loss in the working-age population and is characterized by the disruption of the blood–retinal barrier (BRB) integrity and increased vascular permeability. Elevated vascular endothelial growth factor (VEGF) contributes to BRB dysfunction in DR. Current therapies for DR, including anti-VEGF agents, have provided significant clinical benefits; however, not all patients respond optimally, highlighting the need for new therapeutic approaches. Norrin, an endogenous cytokine essential for blood–retinal barrier development and maintenance, has emerged as a potential therapeutic target for restoring barrier function in retinal vascular disease. In this review, we summarize the evidence supporting norrin signaling as a mechanism for restoring BRB properties following VEGF-induced barrier disruption and in DR, as well as its role in preserving visual function. We also discuss the development of engineered FZD4 agonists designed to mimic or enhance norrin signaling, providing a therapeutic strategy to activate this pathway independently of endogenous norrin. Together, these findings highlight norrin-FZD4 signaling as a potential therapeutic approach to restore BRB integrity and preserve vision in DR and other blinding diseases associated with BRB dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan Ann Arbor, MI 48105, USA.
ORCID-Profile: Laura González-González, David A Antonetti
Förderung
- NEI NIH HHS
- National Eye Institute
Zitieren
APA
González-González, L., & Antonetti, D. A. (2026). Restoration of the Inner Blood–Retinal Barrier in Diabetic Retinopathy Through Norrin-FZD4 Signaling. International Journal of Molecular Sciences, 27(21), 9849. https://doi.org/10.3390/ijms27219849
Vancouver
González-González L, Antonetti DA. Restoration of the Inner Blood–Retinal Barrier in Diabetic Retinopathy Through Norrin-FZD4 Signaling. International Journal of Molecular Sciences. 2026;27(21):9849. doi:10.3390/ijms27219849
BibTeX
@article{GonzlezGonzlez2026,
author = {González-González, Laura and Antonetti, David A},
title = {Restoration of the Inner Blood–Retinal Barrier in Diabetic Retinopathy Through Norrin-FZD4 Signaling},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9849},
doi = {10.3390/ijms27219849}
}
EUVIMED